The CGGA research group has identified a new fusion protein found in approximately 15 percent of secondary glioblastomas.
We hypothesized that key signaling pathways of glioma genesis might enable the molecular classification of gliomas.
In the year 2004, under the guide of Academician, Zhongcheng Wang, the first comprehensive glioma center was built in China. Dr. Tao Jiang is the director of comprehensive Glioma center. Jiang's research mainly focuses on translational medicine and molecular classification of gliomas. And through nearly ten years' sample collection, Prof. Jiang has built the largest glioma tissue bank with particular follow-ups in China. Hundreds of samples have been subjected to whole genome microRNA, mRNA and DNA methylation profiling. In the year 2012, Chinese Glioma Genome Atlas (CGGA) was built, which represented a landmark to glioma research in China. And this will provide massive amounts of data for the research both in basic and clinical research of gliomas.